Skip to content

Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders

Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders, An Effectiveness Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01690494
Acronym
PACT
Enrollment
480
Registered
2012-09-21
Start date
2013-06-11
Completion date
2017-09-30
Last updated
2018-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexually Transmitted Diseases, Substance-Related Disorders, Unsafe Sex

Keywords

STI, sexually transmitted infection, HIV, criminal justice, probation, couples, drug use

Brief summary

This study is a randomized controlled trial (RCT) that will rigorously evaluate the implementation, effectiveness and cost-effectiveness of a couple-based integrated human immunodeficiency virus (HIV) and drug abuse prevention intervention (Connect II) with drug-involved male offenders charged with misdemeanors and their primary female sexual partners, implemented by frontline providers in Criminal Court, Community Court or probation (CCP) sites in NYC, compared to CCP standard treatment of care services (TAU). The primary outcomes are to reduce sexually transmitted infections (STIs) and increase condom use.

Detailed description

HIV/acquired immune deficiency syndrome (AIDS) and criminal justice involvement are critical intersecting public health issues for drug-involved men. Low income, Black and Hispanic men especially bear the burden of the HIV epidemic and are over-represented in the U.S. criminal justice system. Recent Centers for Disease Control and Prevention (CDC) surveillance data suggest that the health disparity in HIV rates is actually increasing for Black men: current estimates suggest 1 in 16 Black men in the U.S. will be infected with HIV in their life time. These HIV/STI transmission risks are fueled by high rates of poverty, incarceration, unemployment, and lack of access to health care and prevention services. The proposed study thus targets an underserved population at the epicenter of the epidemic in the U.S.

Interventions

BEHAVIORALPACT

Couple-based behavioral HIV/STI preventive intervention

BEHAVIORALTAU

Standard treatment of care services provided to male offenders by the Criminal Court, Community Court or probation sites

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Couples * Both partners are aged 18 or older * Identify each other as their primary sexual partner of opposite sex * Relationship has existed at least 3 months * At least one partner reports having unprotected vaginal or anal intercourse with the other partner in the past 90 days * At least one partner reports exposure to an outside HIV risk in the past year * Male partner reports and is verified by court records of being charged with a misdemeanor * Male partner is currently under court supervision or probation

Exclusion criteria

* Either partner shows evidence of significant psychiatric or could impairment as confirmed by the MacArthur Competence Assessment Tool during the screening eligibility interview. * Either partner reports severe physical or sexual violence perpetrated by the other partner in the past year as measured on the Revised Conflict Tactics Scale * Either partner is unable to commit to participate in the study through to completion * Either partner reports that the couple is planning a pregnancy within the next 12 months * Either partner is not fluent in English as determined during Informed Consent

Design outcomes

Primary

MeasureTime frame
Change in biologically confirmed sexually transmitted infectionsBaseline and up to 12 months post intervention
Change in proportion of unprotected sexual actsBaseline and up to 12 months post intervention

Secondary

MeasureTime frame
Change in drug useBaseline and up to 12 months post intervention
Change in utilization of drug treatmentBaseline and up to 12 months post intervention
Change in recidivismUp to 12 months post intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026